|
    
|
|
|
|
|
|
|
|
 |
Cover Article
National Survey Sharpens Picture of Major Depression Among US Adults
The new analysis of data from the 2001-2002 National Epidemiologic Survey of Alcoholism and Related Conditions has shown for the first time that middle age, Native American ethnicity, female gender, low income, and separation, divorce, or widowhood increase the likelihood of current or lifetime major depressive disorder. Asian, Hispanic, and Black race/ethnicity reduce that risk. The findings were published in the October Archives of General Psychiatry.
Selected Articles
|
| |
|
|
|
 |
Cover Article
Better Depression Remission May Be Found in SSRIs
Paroxetine and sertraline, two selective serotonin reuptake inhibitors, were superior to venlafaxine, a serotonin and norepinephrine reuptake inhibitor, in achieving and maintaining remission in patients with depression, according to Suhayl J. Nasr, MD. The study, presented at the 158th Annual Meeting of the American Psychiatric Association, was conducted to counter data from what Dr. Nasr believed were studies with follow-up periods too short to allow for typic al response such as relapse.
Selected Articles
|
| |
|
|
|
 |
Cover Article
Atypical AntipsychoticsFirst-Line Therapies for Bipolar Depression?
Atypical antipsychotics have begun to show potential in the acute treatment of depressive symptoms in patients with bipolar disorder, according to Keming Gao, PhD. Dr. Gao reported on the use of atypical antipsychotics in the treatment of bipolar disorder at the 158th Annual Meeting of the American Psychiatric Association. The findings are significant, he asserted, because depression is now viewed as being more likely than mania to cause impairment in patients with bipolar disorder.
Selected Articles
|
| |
|
|
|
 |
Cover Article
The Evolution of Neuropsychiatry
Although widespread disagreement persists regarding what the field of neuropsychiatry should encompass, the intertwining of brain and thought and of mind and body is central to any definition, according to Stuart C. Yudofsky, MD. The focus is on prevention, assessment, and treatment of psychiatric illnesses and symptoms associated with brain lesions and dysfunctions," he said at the 158th Annual Meeting of the American Psychiatric Association.
Selected Articles
|
| |
|
|
|
 |
Cover Article
Taking Aim at Targeted Treatment of Depression
Despite the official sanction of a one-effect-fits-all approach for prescribing antidepressants, survey data of antidepressant drug selection by psychiatrists suggest that clinicians continue to choose an agent based on such factors as the patients symptoms or the drugs profile, including its purported effectiveness. The reasons for this stark disconnect between evidence-based protocols and clinical practice were elaborated in two presentations at the 158th Annual Meeting of the American Psychiatric Association.
Selected Articles
|
| |
|
|
|
 |
Cover Article
Antipsychotic Use in Elderly Patients With Dementia Prompts New FDA Warning
The use of atypical antipsychotic medications for treating behavioral disorders in elderly patients with dementia is associated with increased mortality, primarily due to cardiac-related events, according to the FDA. Therefore, the agency has requested on all antipsychotic medications the inclusion of a black box warning describing this risk and noting that the drugs are not FDA-approved for the treatment of dementia.
Selected Articles
|
| |
|
|
|
 |
Cover Article
The Neuroanatomy of Personality
Advances in neuroimaging combined with innovative applications of established psychiatric toolssuch as the Five-Factor Model of Personalityare enabling researchers to map the neuroanatomy of personality. Katherine P. Rankin, PhD, reported on the application of psychocartography to frontotemporal lobar degeneration at the 16th Annual Meeting of the American Neuropsychiatric Association in Bal Harbour, Florida.
Selected Articles
|
| |
|
|
|
 |
Cover Article
Should Apathy Be Included in the DSM-V?
The case for why apathy should be included as a stand-alone disorder in the next revision of the DSM was made at the 16th Annual Meeting of the American Neuropsychiatric Association, as was an elucidation of some of the hurdles such a decision would involve.
Selected Articles
|
| |
Copyright
©2007 by Quadrant HealthCom Inc.
7 Century
Dr, Suite 302
Parsippany, NJ 07054-4609
telephone (973) 206-3434 | fax (973) 206-9378
Advertising: sales@neuropsychiatryreviews.com
|